StockVS

Cambridge Acquisition Corp. (CAQ) Stock Analysis

Financial Services

Cambridge Acquisition Corp.

$9.88

+$0.03 (+0.30%)

Last Updated: May 26, 2026

Price History

Analysis

Company Overview

Cambridge Acquisition Corp. is a specialized entity focused on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. This strategic positioning places the company squarely within the Financial Services sector, specifically operating in the niche industry of Shell Companies, which implies a transitional state awaiting a definitive business combination rather than an active operational business. The company currently holds a market capitalization of $230.49M, while specific annual revenue and employee count metrics are not disclosed in the available financial data. These figures indicate that the company exists as a capital-raised vehicle with significant equity value but lacks the traditional revenue-generating operations or workforce associated with mature shell companies, reflecting its status as a pre-transaction entity waiting for a target to finalize a business combination.

Financial Health

The company reports a net income of $-379,068 for the trailing twelve months, while revenue, EBITDA, and free cash flow figures are not available in the provided dataset. The absence of reported revenue combined with a negative net income reveals a cost structure entirely driven by organizational overhead and transaction-related expenses rather than operational profitability. Gross margin, operating margin, and profit margin are all recorded at 0.0%, which indicates that the company is not generating revenue from sales or services, a characteristic typical of shell companies prior to a merger. The company's balance sheet shows no disclosed cash or debt, alongside a debt-to-equity ratio that is not applicable, suggesting a capital structure currently dependent on the trust account proceeds rather than external borrowing. The current ratio stands at 0.05, a figure that indicates extremely limited short-term liquidity relative to current liabilities, underscoring the high-risk nature of the shell company status where liabilities often include significant deferred underwriting fees. Return on equity and return on assets are both marked as not available, which reveals that management effectiveness cannot be measured by traditional performance metrics until a business combination generates earnings.

Valuation Assessment

The trailing P/E ratio and forward P/E ratio are both listed as not applicable, which implies that the market cannot currently price in expected earnings growth based on historical or projected profitability. The price-to-book ratio is recorded at -1635.00, a negative figure that indicates the market capitalization exceeds the book value by an extreme margin due to the negative net assets or trust account structure typical of SPACs. Since price-to-sales and EV/EBITDA ratios are not available, alternative valuation metrics that typically rely on revenue or earnings multiples cannot be utilized to assess the company's value relative to peers. The 52-week high is $10.10 and the 52-week low is $9.80, placing the current market context within a narrow trading band of just 30 cents. Given the current market capitalization of $230.49M and the lack of a specific share price in the source data, the valuation relies heavily on the trust account balance rather than operational cash flows. The beta value is not available, meaning the stock's volatility relative to the broader market cannot be quantified with the current data.

Growth & Income

Revenue growth year-over-year and earnings growth year-over-year are both listed as not available, preventing any analysis of whether earnings are growing faster or slower than revenue. The company does not pay dividends, as the dividend yield and payout ratio are not applicable, which means the company reinvests all available capital into the search for a merger target rather than distributing income to shareholders. This reinvestment strategy is standard for shell companies, where the primary objective is capital preservation and eventual business combination rather than income generation. Consequently, the overall growth and income profile is defined by potential future transformation rather than current operational expansion or shareholder yield, leaving the financial trajectory entirely dependent on the successful completion of a future business combination.

Peer Comparison

Cambridge Acquisition Corp. (CAQ) operates in the Shell Companies industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Cambridge Acquisition Corp. CAQ $247.90M N/A
Twenty One Capital, Inc. XXI $2.49B N/A
Churchill Capital Corp X CCCX $711.00M N/A
Drugs Made In America Acquisition II Corp. DMII $641.46M 77.5

The Shell Companies industry average P/E ratio is 82.8x. Cambridge Acquisition Corp. trades at a P/E of N/A.

This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.

About Cambridge Acquisition Corp.

Cambridge Acquisition Corp. does not have significant operations. focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2025 and is based in Boston, Massachusetts.

Key Statistics

Market Cap
$247.90M
P/E Ratio
N/A
52-Week High
$10.10
52-Week Low
$9.80
Avg Volume
7.80K

Data provided by Yahoo Finance via yfinance. Updated daily.

Company Info

Exchange
NASDAQ
Country
United States